Search for: "CVS CAREMARK" Results 221 - 240 of 297
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
7 Dec 2023, 11:17 am by Seeger Weiss
This appointment positions Buchanan at the forefront of a critical legal battle against insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi – who control nearly the entire U.S. insulin market – as well as the nation’s three largest pharmacy benefit managers (PBMs), CVS Caremark, Express Scripts, and OptumRx, over allegations these companies used unlawful, unfair, and deceptive practices to aggressively hike the cost of insulin and other diabetes medications.… [read post]
13 Aug 2009, 5:00 am
  Here are the numbers:  Apple – 51.6% (two years in a row) Hain Celestial – 62% KB Homes – 50.8%[1]   Edison International – 51% Lexmark International – 69.0% (two years in a row) Pfizer – 52.5% Honeywell – 54.4% Marathon Oil – 50.2% Valero Energy – 50%+ (company didn’t release; three years in a row) CVS Caremark –… [read post]
27 Mar 2012, 9:28 am
Medical experts have recently expressed concern over prescription drug errors, following a mishap at the hands of CVS Caremark Pharmacy last week. [read post]
2 Apr 2012, 1:00 pm by Rob Stigile
Before the acquisition, Medco led the pharmacy benefits management market while Express Scripts ranked third behind CVS Caremark. [read post]
18 Aug 2008, 5:41 pm
1    Wachtell, Lipton, Rosen & Katz    Corporate Transactions for Altria; Bank of America; Cardinal Health; Home Depot; Sears Holdings; Walgreen's; Labor Litigation for Citigroup; Travelers; 2    Cravath, Swaine & Moore LLP Corporate Transactions for Citigroup; IBM; JP Morgan Chase; Kraft; Pfizer; Commercial Litigation for Alcoa; 3    Sullivan & Cromwell… [read post]
3 Jul 2012, 11:16 am by William MacDonald
Other companies that have settled similar charges with the FTC include Rite Aid, Twitter, Dave & Buster's and CVS Caremark. [read post]
21 Jan 2011, 6:38 am by FDABlog HPM
Senate (see our previous posts here and here) critical of the Agency’s recent characterization of the 12-year reference product exclusivity period provided by the Biologics Price Competition and Innovation Act of 2009 (“BPCIA”) as “marketing exclusivity” rather than “data exclusivity,” several generic drug manufacturers (Hospira, Momenta Pharmaceuticals, Hospira, Mylan Labs, Teva Pharmaceuticals, and Watson Pharmaceuticals) and other companies and… [read post]
22 Apr 2009, 2:35 pm
Though the FTC is targeting primarily high-profile, large-scale consumer cases, the agency recently entered into a consent order with CVS Caremark to settle charges that the company had failed to take reasonable and appropriate security measures to protect the sensitive financial and medical information of its customers and employees, in violation of federal law. [read post]
6 Jun 2016, 6:12 pm by Kevin LaCroix
MedPartners later became Caremark RX, Inc., which subsequently merged with CVS to form CVS Caremark Corporation. [read post]
9 Jan 2019, 7:40 am by Beth Graham
CVS Caremark Corp., 748 F.3d 249, 262-63 (5th Cir. 2014); Petrofac, Inc. v. [read post]
24 Aug 2007, 8:04 am
Melvin Watt of North Carolina asked Chairman Cox about the NYSE proposal and expressed concern about the disputed election at CVS/Caremark. [read post]
27 Apr 2009, 9:43 am
CVS TO PAY $2.25M TO SETTLE PRIVACY CASE, In re CVS Caremark Corp., 25 No. 3 Andrews Pharmaceutical Litig. [read post]
28 Mar 2008, 7:25 am
Church groups submitted proposals at CVS Caremark and other health care firms that focus on corporate lobbying efforts to maintain the status quo. [read post]
23 Feb 2016, 6:51 am by Sean Wajert
CVS Caremark Corp., 636 F.3d 971, 973 (8th Cir.2011). [read post]